Navigation Links
Varian Medical Systems and Stanford University Win $3.6 Million Five-Year NIH/NCI Research Grant to Develop Advanced Imaging Technology
Date:10/11/2010

ever, megavoltage imaging also has significant disadvantages.  "You need a lot of dose, and the quality of images is poor, particularly in soft tissues," Star-Lack said.  "Our research grant will be used to develop tools to achieve the best of both worlds by combining kilovoltage cone-beam CT data with a limited amount of megavoltage data to create a composite image with less distortion and good soft tissue resolution."

As part of the project, researchers from Varian and Stanford will develop new megavoltage X-ray detection hardware and image reconstruction software, and will validate the new technology in a clinical trial to be conducted by Stanford.

"The rapid translation of these advances into clinical practice could improve the accuracy of radiotherapy planning and image guidance for patients with metal objects near the targeted tumors," Fahrig said.  "This is a unique grant program that recognizes the special synergies that can happen when academic researchers, who often focus on pure science, collaborate with industrial researchers, who often emphasize product-oriented R&D with near-term commercial possibilities."

The Ginzton Technology Center (GTC) serves as Varian Medical Systems' central R&D organization, incubating new technologies, supporting product development for the company's business units, and conducting government or industry-sponsored research projects. The GTC's mandate is to focus on the investigation of development of new, disruptive, "breakout" technologies that will create significantly improved capabilities for Varian's customers.

About Varian Medical SystemsVarian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiother
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... -- A new report by Allied Market ... End user, Application and Geography) - Size, Share, Global ... Segmentation and Forecast, 2013 - 2020", considers commercial aspects ... trends tracked, it is anticipated that the market is ... registering a CAGR of 6.2% from 2014 to 2020. ...
(Date:10/22/2014)... Oct. 21, 2014   BioNano Genomics , ... genomics research centers to purchase an Irys™ System ... National Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) ... Irys, obtaining a comprehensive view of a genome ... (NGS) does not deliver the scalability or reliability ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... Calif., Oct. 6 PRO-DEX, INC. (Nasdaq: PDEX ... as Chief Financial Officer, effective October 6, 2010.  Mr. Hurwitz ... "Hal comes to Pro-Dex with a broad financial background ... with Coopers & Lybrand LLP, now part of PricewaterhouseCoopers LLP, ...
... DiFUSION Technologies Inc., a medical device company focused ... CleanFUZE™ anti-microbial technology for orthopedic implants, announced today ... of posterior interbody devices indicated for intervertebral body ... SI, in skeletally mature patients who have had ...
Cached Medicine Technology:Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer 2DiFUSION Technologies Receives 510(k) Clearance of Xiphos™ Interbody Implants for Spinal Fusion 2
(Date:10/22/2014)... On October 22, CBS will air an ... both fictional and real. The Charles E Holman ... to advocacy and philanthropy in the battle against Morgellons ... to impart truth and clarity about this misunderstood and ... misconceptions about Morgellons Disease (MD) and most ...
(Date:10/22/2014)... 22, 2014 Isabel Healthcare ... Health Professions (ASAHP) Conference on October 22-24 in Las ... participate in a panel discussion on Technology in Health ... Healthcare provides a diagnostic decision support tool and clinical ... skills of students and clinical learners. The Isabel tools ...
(Date:10/22/2014)... Amy Norton HealthDay Reporter ... remain riveted on the three Ebola cases in Dallas. But, ... health threat to Americans. President Barack Obama on Friday ... the virus, which has infected two Dallas nurses who cared ... at Texas Health Presbyterian Hospital. But the U.S. cases ...
(Date:10/22/2014)... Shriners Hospitals for Children® and UK ... current location of Shriners Hospitals for Children - Lexington ... the University of Kentucky Albert B. Chandler Hospital. The ... owned and operated by Shriners Hospitals for Children, and ... and their families well into the future. , “The ...
(Date:10/22/2014)... California (PRWEB) October 22, 2014 Hay House ... Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) written ... of Yoga & Recovery. This book is meant to ... in a life of recovery. , Recovery 2.0 is ... 12 Steps; Recovery 2.0 is a guide for what comes ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3
... 2008 Vaccinating infants and toddlers is an almost universal ... a regular part of medical care for senior citizens and ... August 2008 issue of the American Journal of Preventive ... in getting vaccines to the adolescent population. , In response ...
... 7 Most of us opt for bottled,water as ... while on the go. Now Filters Fast,( http://www.filtersfast.com ), ... and eco-friendly alternative with its new reusable,filtered water bottles. ... or,water fountain, and the bottles will filter the water ...
... Haemonetics,Corporation (NYSE: HAE ) will announce its Q1FY09 earnings on August ... Conference Call Dial-In Information (888) 802-8577 (US ... #: 54880152 This call will be replayed through August 15, ... (800) 642-1687 (US & Canada) (706) 645-9291 ...
... expected to grow over ... 150% from 2007 second quarter, ... manufacturer and marketer of state-of-the-art cardiac,surgery products and services, today ... 2008., (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO ), The Company currently ...
... people are becoming more positive towards surrogate mothers, ... negative, a scientist will tell the 24th annual ... and Embryology tomorrow (Monday 7 July). Professor Olga ... Middlesex University, Hendon, London, UK, will say that ...
... University of Washington have reported a significant reduction of ... syrup xylitol, a naturally occurring non-cavity-causing sweetener. Their,results were ... International Association for Dental Research. , In a recent ... children 6 to 15 months old were given oral ...
Cached Medicine News:Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 2Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 3Health News:Filters Fast Advocates Use of Filtered Water Bottles for Environmental and Personal Health 2Health News:ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million 2Health News:ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million 3Health News:Surrogacy still stigmatized, though attitudes changing among younger women 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: